Aspartame-induced fibromyalgia, an unusual but curable cause of chronic pain

Clinical and Experimental Rheumatology

Volumn 28, Issue 6 SUPPL. 63, 2010, Pages

  Ciappuccini, R ^a   Ansemant, T ^a   Mailiefert, J F ^a,b   Tavernier, C ^a   Ornetti, P ^a,b,c  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c HÔPITAL DU BOCAGE   (France)

Author keywords

Adverse effect; Aspartame; Chronic pain; Diet; Fibromyalgia

Indexed keywords

ASPARTAME;

ADULT; ARTICLE; CASE REPORT; CHRONIC PAIN; DIETARY INTAKE; FATIGUE; FEMALE; FIBROMYALGIA; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; SLEEP DISORDER; TREATMENT FAILURE; CHEMICALLY INDUCED DISORDER; FEEDING BEHAVIOR; MIDDLE AGED; PAIN; REMISSION;

ADULT; ASPARTAME; FEMALE; FIBROMYALGIA; FOOD HABITS; HUMANS; MALE; MIDDLE AGED; PAIN; REMISSION INDUCTION;

EID: 79952683350     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. CLAUW DJ: Fibromyalgia: an overview. Am J Med 2009; 122 (12 Suppl.): S3-S13.
2. BENNETT RM: Clinical manifestations and diagnosis of fibromyalgia. Rheum Dis Clin North Am 2009; 35: 215-32.
3. ABLIN JN, BAR-SHIRA A, YARON M, ORRURTREGER A: Candidate-gene approach in fibromyalgia syndrome: association analysis of the genes encoding substance P receptor, dopamine transporter and alpha 1-antitrypsin. Clin Exp Rheumatol 2009; 27 (Suppl. 56): S33-8.
4. DI FRANCO M, IANNUCCELLI C, ALESSANDRI C et al.: Autonomic dysfunction and neuropeptide Y in fibromyalgia. Clin Exp Rheumatol 2009; 27 (Suppl. 56): S75-8.
5. BRADLEY LA: Pathophysiology of fibromyalgia. Am J Med 2009; 122 (12 Suppl.): S22-30.
6. MALEMUD CJ: Focus on pain mechanisms and pharmacotherapy in the treatment of fibromyalgia syndrome. Clin Exp Rheumatol 2009; 27 (Suppl. 56): S86-91.
7. SMITH JD, TERPENlNG CM, SCHMIDT SO, GUMS JG: Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother 200, ; 35: 702-6.
8. Wolfe F, Smythe HA, Yunus MB et al.: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-72. (Pubitemid 20098653)
9. MAGNUSON BA, BURDOCK GA, DOULL J et al.: Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol 2007; 37: 629-727.
10. BUTCHKO HH, STARGEL WW: Aspartame: scientific evaluation in the postmarketing period. Regul Toxicol Pharmacol 2001; 34: 221-33.
11. OLNEY JW, FARBER NB, SPITZNAGEL E, ROBINS LN: Increasing brain tumor rates: is there a link to aspartame? J Neuropathol Exp Neurol 1996; 55: 1115-23.
12. Butchko HH, Stargel WW, Comer CP et al.: Aspartame: review of safety. Regul Toxicol Pharmacol 2002; 35 (2 Pt 2): S1-93.
13. RENWICK AG, NORDMANN H: First European conference on aspartame: putting safety and benefits into perspective. Synopsis of presentations and conclusions. Food Chem Toxicol 2007; 45: 1308-13.